| Financial Year |
March 31 2023 |
| Monetary Funds |
1,510,310,399.79 |
| Held-for-trading Financial Assets |
369,000,000.00 |
| Notes Receivable |
14,678,208.96 |
| Accounts Receivable |
180,725,372.60 |
| Advances to Suppliers |
492,330,160.03 |
| Other Receivables |
30,969,073.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
74,094,019.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
65,753,845.12 |
| Total Current Assets |
2,798,404,603.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
153,564,590.74 |
| Investment Properties |
-- |
| Fixed Assetes |
243,110,832.61 |
| Under-construction Projects |
109,986,907.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,776,653.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,228,866.17 |
| Deferred Income Tax Assets |
6,770,000.66 |
| Other Non-Current Assets |
4,274,518.11 |
| Sub-Total of Non-Current Assets |
582,030,453.93 |
| Total Assets |
3,380,435,057.55 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
316,906,329.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,219,819.94 |
| Taxes Payable |
70,959,530.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,036,665.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,206,081.38 |
| Other Current Liabilities |
83,648,197.63 |
| Sub-Total of Current Liabilities |
1,462,202,486.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,007,973.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,390,248.60 |
| Total Liabilities |
1,466,592,734.79 |
| Paid-In Capital(Or Share Stock) |
260,603,073.00 |
| Capital Surplus |
583,428,805.27 |
| Surplus Reserve |
133,076,956.07 |
| LESS:Treasury Stock |
154,308,632.15 |
| Undistributed Profits |
1,085,060,421.14 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,913,842,322.76 |
| Owner's Equity（Stockholder's Equity） |
1,913,842,322.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,380,435,057.55 |
